Scott & Selber, Inc. Eli Lilly & CO Transaction History

Scott & Selber, Inc.

$359 Million
Q2 2025

A detailed history of Scott & Selber, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Scott & Selber, Inc. holds 2,138 shares of LLY stock, worth $1.77 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

2,138

Previous 2,120 0.85%

Holding current value

$1.77 Million

Previous $1.75 Million 4.8%

% of portfolio

0.46%

Previous 0.56%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$713.71 - $898.95 $12,846 - $16,181	18 Added 0.85%	2,138 $1.67 Million
Q4 2024 Feb 06, 2025	BUY	$727.2 - $932.06 $727 - $932	1 Added 0.05%	2,120 $1.64 Million
Q3 2024 Nov 01, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 0.7%	2,119 $1.88 Million
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $10,873 - $13,635	15 Added 0.71%	2,134 $1.93 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $6,514 - $8,715	-11 Reduced 0.52%	2,119 $1.65 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $3,151 - $3,714	-6 Reduced 0.28%	2,130 $1.24 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $434 - $599	-1 Reduced 0.05%	2,136 $1.15 Million
Q2 2023 Jul 27, 2023	BUY	$350.74 - $468.98 $6,313 - $8,441	18 Added 0.85%	2,137 $1 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $1,553 - $1,824	5 Added 0.24%	2,119 $728,000
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $9,324 - $10,865	29 Added 1.39%	2,114 $773,000
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $618,160 - $704,458	2,085 New	2,085 $674,000
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $751,008 - $933,312	-3,200 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$224.85 - $279.04 $719,520 - $892,928	3,200 New	3,200 $884,000

Others Institutions Holding LLY

# of Institutions

4,452

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $785B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scott & Selber, Inc. with notifications on news.

Account